Psyence Biomedical Ltd.
PBMWW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $121.6K in total; no superinvestor holds it.
Other share classesPBM
Q1 2026 vs. Q4 2025
How the institutions holding Psyence Biomedical Ltd. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 21 | 19 | −2 |
| Shares | 5.50M | 5.29M | −208.2K (−3.8%) |
| Value | $101.1K | $96.6K | −$4.45K (−4.4%) |
New holders (1)
Institutions that held Psyence Biomedical Ltd. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 247 | $4 | 0.00% |
Sold out (3)
Institutions that held Psyence Biomedical Ltd. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Advisor Group Holdings, Inc. | 100,000 | $2.00K |
| Susquehanna International Group, LLP | 73,027 | $1.44K |
| SkyView Investment Advisors, LLC | 17,500 | $0 |